CD133 expression is associated with less DNA repair, better response to chemotherapy, and survival in ER-positive/ER-negative breast cancer

被引：0
|
作者：
Sato, Takumi
Oshi, Masanori
Lee, Jing
Roy, Arya M.
Chida, Kohei
Endo, Itaru
Obayashi, Masato
Takabe, Kazuaki
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-2520
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2520
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The Molecular Anatomy of Breast Cancer Stroma; Independent Prognostic Role in ER-Positive and ER-Negative Cancers.
    Bianchini, G.
    Alvarez, R. H.
    Qi, Y.
    Hatzis, C.
    Iwamoto, T.
    Shiang, C.
    Coutant, C.
    Hortobagyi, G. N.
    Symmans, W. F.
    Pusztai, L.
    CANCER RESEARCH, 2009, 69 (24) : 507S - 507S
  • [22] MIR-190B-5P EXPRESSION IS A HIGHLY RELIABLE DISCRIMINATOR BETWEEN ER-POSITIVE AND ER-NEGATIVE BREAST CANCER
    Iyevleva, A.
    Bizin, I.
    Sokolenko, A.
    Venina, A.
    Anisimova, E.
    Holmatov, M.
    Romanko, A.
    Stepanov, I.
    Togo, A.
    Imyanitov, E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A181 - A181
  • [23] Relationship between RUNX1 and AXIN1 in ER-negative versus ER-positive Breast Cancer
    Chimge, Nyam-Osor
    Ahmed-Alnassar, Sara
    Frenkel, Baruch
    CELL CYCLE, 2017, 16 (04) : 312 - 318
  • [24] Identification of key genes relevant to the prognosis of ER-positive and ER-negative breast cancer based on a prognostic prediction system
    Xiao, Bin
    Hang, Jianfeng
    Lei, Ting
    He, Yongyin
    Kuang, Zhenzhan
    Wang, Li
    Chen, Lidan
    He, Jia
    Zhang, Weiyun
    Liao, Yang
    Sun, Zhaohui
    Li, Linhai
    MOLECULAR BIOLOGY REPORTS, 2019, 46 (02) : 2111 - 2119
  • [25] Identification of key genes relevant to the prognosis of ER-positive and ER-negative breast cancer based on a prognostic prediction system
    Bin Xiao
    Jianfeng Hang
    Ting Lei
    Yongyin He
    Zhenzhan Kuang
    Li Wang
    Lidan Chen
    Jia He
    Weiyun Zhang
    Yang Liao
    Zhaohui Sun
    Linhai Li
    Molecular Biology Reports, 2019, 46 : 2111 - 2119
  • [26] Radiation Therapy Use and Outcomes Among Older Women With ER-Positive and ER-Negative Stage I Breast Cancer
    Shen, Xinglei
    Anne, Pramila R.
    Keith, Scott W.
    Wojcieszynski, Andrzej
    Mishra, Mark V.
    Bar-Ad, Voichita
    Showalter, Timothy N.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (03): : 241 - 247
  • [27] ANALYSIS OF THE ESTROGEN-RECEPTOR (ER) GENE, TRANSCRIPT AND PROTEIN IN ER-POSITIVE AND ER-NEGATIVE BREAST-CANCER CELL-LINES
    YAICH, LE
    ROODI, N
    BAILEY, LR
    VERRIER, CS
    YEE, CJ
    CAVENER, DR
    PARL, FF
    ENDOCRINE-RELATED CANCER, 1995, 2 (04) : 293 - 309
  • [28] Rapid Activation of cPLA2α Induced by Estrogen in ER-Positive and ER-Negative Breast Cancer Cell Lines.
    Caiazza, F.
    Thomas, W.
    Harvey, B. J.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [29] INFLUENCE OF HORMONES ON PROLIFERATION OF ER-POSITIVE CELLS AND ER-NEGATIVE CELLS OF HUMAN-BREAST CANCER (MCF-7)
    NOGUCHI, M
    TAJIRI, K
    TANIYA, T
    KUMAKI, T
    ASHIKARI, A
    MIYAZAKI, I
    ONCOLOGY, 1990, 47 (01) : 19 - 24
  • [30] Clinical Subtype-Derived p53 Gene Signature Is Predictive of Prognosis and Response to Chemotherapy in ER-Positive but Not in ER-Negative Breast Cancers.
    Pusztai, L.
    Rouzier, R.
    Qi, Y.
    Lehmann-Che, J.
    Bianchini, G.
    Iwamoto, T.
    Symmans, W. F.
    Andre, F.
    de The, H.
    Coutant, C.
    CANCER RESEARCH, 2009, 69 (24) : 863S - 863S
12345